Lista de obras -

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

artículo científico publicado en 2006

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

artículo científico publicado en 2006

A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.

artículo científico publicado en 2005

Acceptability of second-step treatments to depressed outpatients: a STAR*D report

artículo científico publicado en 2007

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

artículo científico publicado en 2006

Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care

artículo científico publicado en 2014

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

artículo científico publicado en 2008

Assessing anxious features in depressed outpatients.

artículo científico publicado en 2011

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

artículo científico publicado en 2006

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

artículo científico publicado en 2009

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients

artículo científico publicado en 2013

Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

artículo científico publicado en 2009

Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.

artículo científico publicado en 2004

Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis

artículo científico publicado en 2007

Clinically Relevant Findings from STAR*D

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

artículo científico publicado en 2007

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

artículo científico publicado en 2011

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features

artículo científico publicado en 2005

Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.

artículo científico

Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.

artículo científico

Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome

artículo científico publicado en 2008

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

artículo científico publicado en 2008

Do atypical features affect outcome in depressed outpatients treated with citalopram?

artículo científico publicado en 2009

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study

artículo científico publicado en 2013

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

artículo científico publicado en 2010

Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report

artículo científico

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.

artículo científico publicado en 2010

Effectiveness Study of Venlafaxine-XR Combined with Aripiprazole for Chronic or Recurrent Major Depressive Disorder

scholarly article by Andrew A. Nierenberg et al published January 2009 in Australian and New Zealand Journal of Psychiatry

Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial

Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial

artículo científico publicado en 2011

Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder

artículo científico publicado en 2007

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.

artículo científico publicado en 2006

Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

artículo científico publicado en 2007

Health-related quality of life in depression: a STAR*D report.

artículo científico publicado en 2010

Identifying risk for attrition during treatment for depression

artículo científico publicado en 2009

Income and attrition in the treatment of depression: a STAR*D report.

artículo científico publicado en 2009

Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis

artículo científico publicado en 2007

Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

artículo científico publicado en 2007

Medication augmentation after the failure of SSRIs for depression.

artículo científico publicado en 2006

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report

artículo científico publicado en 2007

Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention

artículo científico publicado en 2009

Quality improvement methods as applied to a multicenter effectiveness trial—STAR*D

artículo científico publicado en 2005

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

artículo científico publicado en 2011

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication

artículo científico publicado en 2011

STAR*D: revising conventional wisdom.

artículo científico publicado en 2009

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

artículo científico

Sex differences in response to citalopram: a STAR*D report

artículo científico publicado en 2008

Substance Use Disorder Comorbidity in Major Depressive Disorder: A Confirmatory Analysis of the STAR*D Cohort

article

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

artículo científico publicado en 2006

The STAR*D Project results: a comprehensive review of findings.

artículo científico publicado en 2007

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

artículo científico publicado en 2006

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

artículo científico publicado en 2004

What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression

article

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression

artículo científico publicado en 2009

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

artículo científico publicado en 2008

Lista de obras de

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.

Acceptability of second-step treatments to depressed outpatients: a STAR*D report

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

Assessing anxious features in depressed outpatients.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients

Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.

Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis

Clinically Relevant Findings from STAR*D

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features

Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.

Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.

Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

Do atypical features affect outcome in depressed outpatients treated with citalopram?

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.

Effectiveness Study of Venlafaxine-XR Combined with Aripiprazole for Chronic or Recurrent Major Depressive Disorder

Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial

Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial

Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.

Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

Health-related quality of life in depression: a STAR*D report.

Identifying risk for attrition during treatment for depression

Income and attrition in the treatment of depression: a STAR*D report.

Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis

Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

Medication augmentation after the failure of SSRIs for depression.

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report

Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention

Quality improvement methods as applied to a multicenter effectiveness trial—STAR*D

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication

STAR*D: revising conventional wisdom.

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

Sex differences in response to citalopram: a STAR*D report

Substance Use Disorder Comorbidity in Major Depressive Disorder: A Confirmatory Analysis of the STAR*D Cohort

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

The STAR*D Project results: a comprehensive review of findings.

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.